Physician profile
Sameer I Ahmad
NPI 1326003401
$554.16
in general payments reported to CMS, 2019-2025
8 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $127 · 2021: $18.99 · 2022: $52.62 · 2023: $41.47 · 2024: $95.43 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $188.68 | 2025 | Idosetr |
| Allergan, INC. | $108.00 | 2020 | |
| Abbvie INC. | $83.16 | 2022-2024 | Durysta, Vuity |
| Alcon Vision LLC | $54.19 | 2024-2025 | Rocklatan, Clareon |
| Sight Sciences, INC. | $53.54 | 2021-2022 | |
| Thea Pharma INC. | $23.99 | 2024 | Iyuzeh |
| Bausch & Lomb Americas INC. | $23.20 | 2024 | Miebo, Vyzulta |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.